Inhibition of Progression of Androgen-Dependent Prostate LNCaP Tumors to Androgen Independence in SCID Mice by Oral Caffeine and Voluntary Exercise

REFERENCES

• Jemal , A , Siegel , R , Xu , J and Ward , E . 2010 . Cancer statistics, 2010 . CA Cancer J Clin , 60 : 277 – 300 .
   PubMed Web of Science ®Google Scholar
• Devlin , H and Mudryj , M . 2009 . Progression of prostate cancer: multiple pathways to androgen independence . Cancer Lett , 274 : 177 – 186 .
   PubMed Web of Science ®Google Scholar
• Schröder , F . 2008 . Progress in understanding androgen-independent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms . Eur Urol , 53 : 1129 – 1137 .
   PubMed Web of Science ®Google Scholar
• Chi , K , Bjartell , A , Dearnaley , D , Saad , F Schröder , F . 2009 . Castration-resistant prostate cancer: from new pathophysiology to new treatment targets . Eur Urol , 56 : 594 – 605 .
   PubMed Web of Science ®Google Scholar
• Morris , M and Scher , H . 2002 . Novel therapies for the treatment of prostate cancer: current clinical trials and development strategies . Surg Oncol , 11 : 13 – 23 .
   PubMed Web of Science ®Google Scholar
• Pilat , M , Kamradt , J and Pienta , K . 1998 . Hormone resistance in prostate cancer . Cancer Metastasis Rev , 17 : 373 – 381 .
   PubMed Web of Science ®Google Scholar
• So , A , Gleave , M , Hurtado-Col , A and Nelson , C . 2005 . Mechanisms of the development of androgen independence in prostate cancer . World J Urol , 23 : 1 – 9 .
   PubMed Web of Science ®Google Scholar
• Raghavan , D , Koczwara , B and Javle , M . 1997 . Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer . Eur J Cancer , 33 : 566 – 574 .
   PubMed Web of Science ®Google Scholar
• Huang , M-T , Xie , J-G , Wang , Z-Y , Ho , C-T Lou , Y-R . 1997 . Effects of tea, decaffeinated tea, and caffeine on UVB light-induced complete carcinogenesis in SKH-1 mice: demonstration of caffeine as a biologically important constituent of tea . Cancer Res , 57 : 2623 – 2629 .
   PubMed Web of Science ®Google Scholar
• Michna , L , Wagner , G C , Lou , Y-R , Xie , J-G Peng , Q-Y . 2006 . Inhibitory effects of voluntary running wheel exercise on UVB-induced skin carcinogenesis in SKH-1 mice . Carcinogenesis , 27 : 2108 – 2115 .
   PubMed Web of Science ®Google Scholar
• Lu , Y-P , Lou , Y-R , Lin , Y , Shih , W Huang , M-T . 2001 . Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): relationship to decreased tissue fat . Cancer Res , 61 : 5002 – 5009 .
   PubMed Web of Science ®Google Scholar
• Lu , Y-P , Lou , Y-R , Li , X-H , Xie , J-G Brash , D . 2000 . Stimulatory effect of oral administration of green tea or caffeine on ultraviolet light-induced increases in epidermal wild-type p53, p21(WAF1/CIP1), and apoptotic sunburn cells in SKH-1 mice . Cancer Res , 60 : 4785 – 4791 .
   PubMed Web of Science ®Google Scholar
• Lu , Y P , Lou , Y R , Nolan , B , Peng , Q Y Xie , J G . 2006 . Stimulatory effect of voluntary exercise or fat removal (partial lipectomy) on apoptosis in the skin of UVB light-irradiated mice . Proc Natl Acad Sci USA , 103 : 16301 – 16306 .
   PubMed Web of Science ®Google Scholar
• Lu , Y-P , Lou , Y-R , Xie , J-G , Peng , Q-Y Liao , J . 2002 . Topical applications of caffeine or (–)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice . Proc Natl Acad Sci USA , 99 : 12455 – 12460 .
   PubMed Web of Science ®Google Scholar
• Lu , Y-P , Lou , Y-R , Peng , Q , Nghiem , P and Conney , A H . 2011 . Caffeine decreases phospho-Chk1 (Ser317) and increases mitotic cells with cyclin B1 and caspase 3 in tumors from UVB-treated mice . Cancer Prev Res , 4 : 1118 – 1125 .
   PubMed Web of Science ®Google Scholar
• Zheng , X , Cui , X-X , Gao , Z , Zhao , Y Lin , Y . 2010 . Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence . Cancer Prev Res , 3 : 114 – 124 .
   PubMed Web of Science ®Google Scholar
• Zheng , X , Cui , X-X , Huang , M-T , Liu , Y Shih , W . 2008 . Inhibitory effect of voluntary running wheel exercise in the growth of human pancreas Panc-1 and prostate PC-3 xenograft tumors in immunodeficient mice . Oncol Rep , 19 : 1583 – 1588 .
   PubMed Web of Science ®Google Scholar
• Zheng , X , Cui , X X , Avila , G E , Huang , M T Liu , Y . 2007 . Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice . Clin Cancer Res , 13 : 5480 – 5487 .
   PubMed Web of Science ®Google Scholar
• Kot , M and Daniel , W . 2007 . Effect of cytochrome P450 (CYP) inducers on caffeine metabolism in the rat . Pharmacol Rep , 59 : 296 – 305 .
   PubMed Web of Science ®Google Scholar
• Lindsey , J K . 1993 . Models for Repeated Measurements , 89 – 96 . Oxford , UK : Claredon Press .
   Google Scholar
• de Leon , J , Diaz , F J , Rogers , T , Browne , D Dinsmore , L . 2003 . A pilot study of plasma caffeine concentrations in a US sample of smoker and nonsmoker volunteers . Prog Neuropsychopharmacol Biol Psychiatry , 27 : 165 – 171 .
   PubMed Web of Science ®Google Scholar
• Norager , C B , Jensen , M B , Weimann , A and Madsen , M R . 2006 . Metabolic effects of caffeine ingestion and physical work in 75-year old citizens. A randomized, double-blind, placebo-controlled, cross-over study . Clin Endocrinol (Oxf) , 65 : 223 – 228 .
   PubMed Web of Science ®Google Scholar
• Lu , Y-P , Lou , Y-R , Peng , Q-Y , Xie , J-G Nghiem , P . 2008 . Effect of caffeine on the ATR/Chk1 pathway in the epidermis of UVB-irradiated mice . Cancer Res , 68 : 2523 – 2529 .
   PubMed Web of Science ®Google Scholar
• Kawamoto , H , Koizumi , H and Uchikoshi , T . 1997 . Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in non-malignant and malignant breast lesions . Am J Pathol , 150 : 15 – 23 .
   PubMed Web of Science ®Google Scholar
• Mashal , R D , Lester , S , Corless , C , Richie , J P Chandra , R . 1996 . Expression of cell cycle-regulated proteins in prostate cancer . Cancer Res , 56 : 4159 – 4163 .
   PubMed Web of Science ®Google Scholar
• Kushner , J , Bradley , G , Young , B and Jordan , R C . 1999 . Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma . J Oral Pathol Med , 28 : 77 – 81 .
   PubMed Web of Science ®Google Scholar
• Murakami , H , Furihata , M , Ohtsuki , Y and Ogoshi , S . 1999 . Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma . Virchows Arch , 434 : 153 – 158 .
   PubMed Web of Science ®Google Scholar
• Maddison , L A , Huss , W J , Barrios , R M and Greenberg , N M . 2004 . Differential expression of cell cycle regulatory molecules and evidence for a “cyclin switch” during progression of prostate cancer . Prostate , 58 : 335 – 344 .
   PubMed Web of Science ®Google Scholar
• Gregory , C W , Johnson , R TJ , Presnell , S C , Mohler , J L and French , F S . 2001 . Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft . J Androl , 22 : 537 – 548 .
   PubMed Web of Science ®Google Scholar
• Gomez , L A , de Las Pozas , A , Reiner , T , Burnstein , K and Perez-Stable , C . 2007 . Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy . Molecular Cancer Theraputics , 6 : 1534 – 1543 .
   PubMed Web of Science ®Google Scholar
• Laskin , D L and Laskin , J D . 2010 . “ Inflammation and cancer ” . In Cancer Medicine , Edited by: Hong , W K , Bast , R C Jr. , Hait , W , Kufe , D W and Pollock , R E . 270 – 278 . Shelton , CT : People's Medical Publishing House .
   Google Scholar
• Mantovani , A , Garlanda , C and Allavena , P . 2010 . Molecular pathway and targets in cancer-related inflammation . Ann Med , 42 : 161 – 170 .
   PubMed Web of Science ®Google Scholar
• Smith , P C , Hobisch , A , Lin , D L , Culig , Z and Keller , E T . 2001 . Interleukin-6 and prostate cancer progression . Cytokine Growth Factor Rev , 12 : 33 – 40 .
   PubMed Web of Science ®Google Scholar
• Chun , J Y , Nadiminty , N , Dutt , S , Lou , W Yang , J C . 2009 . Interleukin-6 regulates androgen synthesis in prostate cancer cells . Clin Cancer Res , 15 : 4815 – 4822 .
   PubMed Web of Science ®Google Scholar
• Hobisch , A , Eder , I E , Putz , T , Horninger , W Bartsch , G . 1998 . Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor . Cancer Res , 58 : 4640 – 4645 .
   PubMed Web of Science ®Google Scholar
• Chung , T D , Yu , J J , Spiotto , M T , Bartkowski , M and Simons , J W . 1999 . Characterization of the role of IL-6 in the progression of prostate cancer . Prostate , 38 : 199 – 207 .
   PubMed Web of Science ®Google Scholar
• Smith , P C and Keller , E T . 2001 . Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice . Prostate , 48 : 47 – 53 .
   PubMed Web of Science ®Google Scholar
• Wallner , L , Dai , J , Escara-Wilke , J , Zhang , J Yao , Z . 2006 . Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice . Cancer Res , 66 : 3081 – 3095 .
   Web of Science ®Google Scholar
• Carillo , J and Benitez , J . 2000 . Clinically significant pharmacokinetic interactions between dietary caffeine and medications . Clin Pharmacokinet , 39 : 127 – 153 .
   PubMed Web of Science ®Google Scholar
• Antonelli , J , Jones , L , Banez , L , Thomas , J-A Anderson , K . 2009 . Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy . J Urol , 182 : 2226 – 2231 .
   PubMed Web of Science ®Google Scholar
• Richman , E L , Kenfield , S A , Stampfer , M J , Paciorek , A Carroll , P R . 2011 . Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor . Cancer Res , 71 : 3889 – 3895 .
   PubMed Web of Science ®Google Scholar
• Park , C-H , Myung , S-K , Kim , T-Y , Seo , H G Jeon , Y-J . 2010 . KORMA Study Group. Coffee consumption and risk of prostate cancer: a meta-analysis of epidemiological studies . BJU Int , 106 : 762 – 769 .
   PubMed Web of Science ®Google Scholar
• Wilson , K M , Kasperzyk , J L , Rider , J R , Kenfield , S van Dam , R M . 2011 . Coffee consumption and prostate cancer risk and progression in the health professionals follow-up study . J Natl Cancer Inst , 103 : 1 – 9 .
   Google Scholar
• McCusker , R R , Feuhrlein , B , Goldberger , B A , Gold , M S and Cone , E J . 2006 . Caffeine content of decaffeinated coffee . J Anal Toxicol , 30 : 611 – 613 .
   PubMed Web of Science ®Google Scholar
• Tsai , H , D’Amico , A , Sadetsky , N , Chen , M and Carroll , P . 2007 . Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality . J Natl Cancer Inst , 44 : 1516 – 1524 .
   Google Scholar
• Saigal , C , Gore , J L , Krupski , T L , Hanley , J Schonlau , M . 2007 . Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer . Cancer , 110 : 1493 – 1500 .
   PubMed Web of Science ®Google Scholar
• D’Amico , A , Denham , J , Crook , J , Chen , M Goldhaber , S . 2007 . Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infractions . J Clin Oncol , 25 : 2420 – 2425 .
   PubMed Web of Science ®Google Scholar